If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "PBM"
Jump to navigation
Jump to search
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
| Line 3: | Line 3: | ||
[https://pubmed.ncbi.nlm.nih.gov/28580093/ Source] | [https://pubmed.ncbi.nlm.nih.gov/28580093/ Source] | ||
| + | ==Companies== | ||
| + | *[[Niraxx Light Therapeutics]] | ||
| + | *[[Vielight]] | ||
| + | *[[McareM]] | ||
Latest revision as of 20:02, 1 May 2022
"Transcranial photobiomodulation (PBM) also known as low level laser therapy (tLLLT) relies on the use of red/NIR light to stimulate, preserve and regenerate cells and tissues. The mechanism of action involves photon absorption in the mitochondria (cytochrome c oxidase), and ion channels in cells leading to activation of signaling pathways, up-regulation of transcription factors, and increased expression of protective genes."